Emtaf-B Tablet is an antiviral medication containing the active constituent Tenofovir alafenamide. It is used to treat chronic hepatitis B virus (HBV) infection. Hepatitis B is an infection affecting the liver caused by the hepatitis B virus. Discuss with your doctor about the precautions needed to avoid infecting others. Tell your doctor if you have or have ever had kidney diseases, liver diseases, or HIV before taking Emtaf-B Tablet. Administration of this medicine may lead to lactic acidosis (accumulation of excessive acid) and hepatomegaly (enlarged liver).
It is not recommended for patients weighing less than 35 kg. This medicine contains lactose. Contact your doctor if you are intolerant to sugars before taking medicine. Tell your doctor if you are breastfeeding or pregnant before taking Emtaf-B Tablet. Do not stop taking this medicine without your doctor’s advice, as it may worsen the condition. The safety and efficacy of this medication in pediatric patients may differ from those in adults. Dosage adjustments and careful monitoring may be necessary for children and the elderly.
Uses of Emtaf-b Tablet
Emtaf-B Tablet is used in the treatment of:
- Hepatitis B virus (HBV) infection
Therapeutic Effects of Emtaf-b Tablet
Its therapeutic effect of Emtaf-B Tablet involves reducing viral replication, lowering a viral load, preserving the immune system, and delaying disease progression in individuals with HIV-1 or HBV.
Interaction of Emtaf-b Tablet with other drugs
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Emtaf-B Tablet, reducing effectiveness by causing undesirable side effects.
More Information about Emtaf-b Tablet
How to consume Emtaf-b Tablet
To consume Emtaf-B Tablet properly, follow your healthcare provider's instructions regarding dosage, frequency, and duration. Take it with or without food, swallowing the tablets or capsules with water. Adhere to the prescribed dosing schedule; do not alter the dosage without consulting your healthcare provider.
Safety Advices for Emtaf-b Tablet
Pregnancy
If you are pregnant or planning to become pregnant, it is crucial to consult with your healthcare provider before taking Emtaf-B Tablet.
Breast Feeding
Emtaf-B Tablet is excreted into human breast milk, but the potential risks to the infant are not well established. So it is better to consult a doctor before taking it.
Lungs
If you have a history of lung disease or are experiencing respiratory symptoms while taking, it is important to consult your healthcare provider for a thorough evaluation before taking Emtaf-B Tablet.
Liver
The safety of Emtaf-B Tablet in individuals with liver disease may depend on the specific type and severity of liver disease and other factors. It is important to consult with a healthcare provider
Alcohol
It is generally recommended to avoid excessive alcohol consumption while taking Emtaf-B Tablet or any medication. Alcohol can interact with this medication and affect liver function.
Driving
People may experience side effects such as dizziness, drowsiness, or fatigue while taking Emtaf-B Tablet. Suppose you experience any of these side effects or any other symptoms that may interfere with your ability to drive safely. In that case, avoid driving or operating heavy machinery.
Side Effects of Emtaf-b Tablet
Emtaf-B Tablet causes some side effects like all medications, although not everyone will experience them.
Serious:
- Too much lactic acid in the blood (unusual weakness, muscle pain, cold hands and feet)
- Severe liver problems (yellow skin and eyes, tea-colored urine, light-colored stools, loss of appetite)
- Severe kidney problems
Common:
- Nausea, vomiting
- Diarrhea
- Stomach pain, joint pain
- Rash, itching
- Feeling tired
- Headache, dizziness
Word of Advice
If you are considering of taking Emtaf-B Tablet, it is important to be aware of the potential risks and warnings associated with the this medication. Pregnancy and breastfeeding require individual evaluation and consultation with a healthcare provider to weigh the benefits against potential risks. It should be used cautiously in individuals with pre-existing conditions such as liver disease, kidney disease, or bone disorders, as it may exacerbate them. Close monitoring and appropriate management are necessary in these cases. Adherence to these precautions and regular monitoring and communication with the healthcare provider can help ensure safe and effective use.
FAQs
Q 1. Can Emtaf-B Tablet be taken with other antiretroviral medications?
Yes, Emtaf-B Tablet is often combined with other antiretroviral medications as part of a multidrug regimen for treating HIV infection. The specific combination of medications will depend on individual health status, treatment history, and potential drug interactions.
Q 2. Can Emtaf-B Tablet be safely used in older adults?
Emtaf-B Tablet can be used in older adults, but dosage adjustments or additional monitoring may be necessary, as age-related changes in kidney and liver function can affect medication clearance. It is important to discuss individual health status and any concerns with a healthcare provider.
Q 3. Can Emtaf-B Tablet cause weight gain?
Weight gain is not a commonly reported side effect of Emtaf-B Tablet. However, individual responses to medications can vary, and some people may experience changes in weight while taking this medication. It is important to discuss any concerns about weight changes with your healthcare provider.
Q 4. Can Emtaf-B Tablet be used during chemotherapy or radiation therapy?
The use of Emtaf-B Tablet in individuals undergoing chemotherapy or radiation therapy should be evaluated on a case-by-case basis, considering potential drug interactions and individual health factors. It is crucial to consult the HIV specialist and oncologist to determine the most appropriate treatment approach.
Q 5. Can Emtaf-B Tablet be taken during surgery or dental procedures?
If you are scheduled for surgery or dental procedures, informing your healthcare provider or dentist about your Emtaf-B Tablet treatment is important. They can guide whether any adjustments need to be made, such as temporary discontinuation or use of other medications during the procedure.
Q 6. Can Emtaf-B Tablet cause lactic acidosis?
Although rare, Emtaf-B Tablet has been associated with the risk of lactic acidosis. Lactic acidosis is a serious condition characterized by the buildup of lactic acid in the blood. It is important to promptly report any symptoms such as unusual weakness, rapid breathing, nausea, vomiting, abdominal pain, or unexplained muscle pain to your healthcare provider while taking it.
Fact Box of Emtaf-b Tablet
Molecule name: Tenofovir alafenamide | Therapeutic class: Antiviral agents |
Pharmacological class: Nucleoside reverse transcriptase inhibitors (NRTIs) | Indications: Hepatitis B infection |